Research has shown us that we may be able to intervene many years before people develop Parkinson's and slow down its progression. Carriers of genetic abnormalities in the GBA gene (which can also cause Gaucher disease) are at increased risk of Parkinson's disease although the vast majority will not develop it.
Rapsodi assesses carriers of GBA genetic abnormalities on a yearly basis for symptoms associated with the earliest stages of Parkinson's disease. Assessments are carried out online and by post. In the future we hope to enrol GBA carriers in drug trials of new medicines designed prevent the development of Parkinson's disease.
Take part in the study
If you have Gaucher disease, are related to someone with Gaucher disease or know you carry an abnormal copy of the GBA gene, please sign up for the study